Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 304 items for :

  • "injections" x
Clear All
Tristan Avril Pediatric Endocrinology Department, CHU Bicetre, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR DevGen, Le Kremlin Bicêtre, Paris, France

Search for other papers by Tristan Avril in
Google Scholar
PubMed Close
,
Quentin Hennocq Datascience platform, Imagine Institute, Université Paris Cité, Paris, France

Search for other papers by Quentin Hennocq in
Google Scholar
PubMed Close
,
Anne-Sophie Lambert Pediatric Endocrinology Department, CHU Bicetre, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR DevGen, Le Kremlin Bicêtre, Paris, France

Search for other papers by Anne-Sophie Lambert in
Google Scholar
PubMed Close
,
Juliane Leger Pediatric Endocrinology Department, CHU Robert Debré, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR de la Croissance et du Développement, Paris, France
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France

Search for other papers by Juliane Leger in
Google Scholar
PubMed Close
,
Dominique Simon Pediatric Endocrinology Department, CHU Robert Debré, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR de la Croissance et du Développement, Paris, France

Search for other papers by Dominique Simon in
Google Scholar
PubMed Close
,
Laetitia Martinerie Pediatric Endocrinology Department, CHU Robert Debré, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR de la Croissance et du Développement, Paris, France
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France

Search for other papers by Laetitia Martinerie in
Google Scholar
PubMed Close
, and
Claire Bouvattier Pediatric Endocrinology Department, CHU Bicetre, Assistance Publique-Hôpitaux de Paris, Reference Center for Rare Disease CRMR DevGen, Le Kremlin Bicêtre, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Paris-Saclay University, Paris, France

Search for other papers by Claire Bouvattier in
Google Scholar
PubMed Close

modalities of gonadotropins administration in two groups of CHH boys, treated during the mini-pubertal period. Multi-weekly injections of recombinant human chorionic gonadotrophin (hCG) and FSH for 3 months was the first modality (injection group). Continuous

Article Type:
Research Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-22-0252
Volume/Issue:
Volume 12: Issue 4
Open access
Nandini Shankara Narayana Andrology Department, Concord Hospital and, ANZAC Research Institute, University of Sydney, Sydney, Australia

Search for other papers by Nandini Shankara Narayana in
Google Scholar
PubMed Close
,
Lam P Ly Andrology Department, Concord Hospital and, ANZAC Research Institute, University of Sydney, Sydney, Australia

Search for other papers by Lam P Ly in
Google Scholar
PubMed Close
,
Veena Jayadev Andrology Department, Concord Hospital and, ANZAC Research Institute, University of Sydney, Sydney, Australia

Search for other papers by Veena Jayadev in
Google Scholar
PubMed Close
,
Carolyn Fennell Andrology Department, Concord Hospital and, ANZAC Research Institute, University of Sydney, Sydney, Australia

Search for other papers by Carolyn Fennell in
Google Scholar
PubMed Close
,
Sasha Savkovic Andrology Department, Concord Hospital and, ANZAC Research Institute, University of Sydney, Sydney, Australia

Search for other papers by Sasha Savkovic in
Google Scholar
PubMed Close
,
Ann J Conway Andrology Department, Concord Hospital and, ANZAC Research Institute, University of Sydney, Sydney, Australia

Search for other papers by Ann J Conway in
Google Scholar
PubMed Close
, and
David J Handelsman Andrology Department, Concord Hospital and, ANZAC Research Institute, University of Sydney, Sydney, Australia

Search for other papers by David J Handelsman in
Google Scholar
PubMed Close

most common route of administration has been the parenteral injection of testosterone as a pro-drug esterified to short-chain aliphatic fatty acids in a vegetable oil vehicle ( 2 ). These injectable products are affordable with depot effects that

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0109
Volume/Issue:
Volume 10: Issue 7
Open access
Eric M Ndombi Bomu Hospital, Department of Pathology, Department of Environment and Health Sciences, Department of Biomedical Sciences and Technology, Department of Medical Laboratory Sciences, Kapkatet Campus, Centre for Virus Research, Department of Medical Laboratory Sciences, Mombasa, Kenya

Search for other papers by Eric M Ndombi in
Google Scholar
PubMed Close
,
Valentine Budambula Bomu Hospital, Department of Pathology, Department of Environment and Health Sciences, Department of Biomedical Sciences and Technology, Department of Medical Laboratory Sciences, Kapkatet Campus, Centre for Virus Research, Department of Medical Laboratory Sciences, Mombasa, Kenya

Search for other papers by Valentine Budambula in
Google Scholar
PubMed Close
,
Mark K Webale Bomu Hospital, Department of Pathology, Department of Environment and Health Sciences, Department of Biomedical Sciences and Technology, Department of Medical Laboratory Sciences, Kapkatet Campus, Centre for Virus Research, Department of Medical Laboratory Sciences, Mombasa, Kenya

Search for other papers by Mark K Webale in
Google Scholar
PubMed Close
,
Francis O Musumba Bomu Hospital, Department of Pathology, Department of Environment and Health Sciences, Department of Biomedical Sciences and Technology, Department of Medical Laboratory Sciences, Kapkatet Campus, Centre for Virus Research, Department of Medical Laboratory Sciences, Mombasa, Kenya

Search for other papers by Francis O Musumba in
Google Scholar
PubMed Close
,
Jesca O Wesongah Bomu Hospital, Department of Pathology, Department of Environment and Health Sciences, Department of Biomedical Sciences and Technology, Department of Medical Laboratory Sciences, Kapkatet Campus, Centre for Virus Research, Department of Medical Laboratory Sciences, Mombasa, Kenya

Search for other papers by Jesca O Wesongah in
Google Scholar
PubMed Close
,
Erick Mibei Bomu Hospital, Department of Pathology, Department of Environment and Health Sciences, Department of Biomedical Sciences and Technology, Department of Medical Laboratory Sciences, Kapkatet Campus, Centre for Virus Research, Department of Medical Laboratory Sciences, Mombasa, Kenya

Search for other papers by Erick Mibei in
Google Scholar
PubMed Close
,
Aabid A Ahmed
Search for other papers by Aabid A Ahmed in
Google Scholar
PubMed Close
,
Raphael Lihana Bomu Hospital, Department of Pathology, Department of Environment and Health Sciences, Department of Biomedical Sciences and Technology, Department of Medical Laboratory Sciences, Kapkatet Campus, Centre for Virus Research, Department of Medical Laboratory Sciences, Mombasa, Kenya

Search for other papers by Raphael Lihana in
Google Scholar
PubMed Close
, and
Tom Were Bomu Hospital, Department of Pathology, Department of Environment and Health Sciences, Department of Biomedical Sciences and Technology, Department of Medical Laboratory Sciences, Kapkatet Campus, Centre for Virus Research, Department of Medical Laboratory Sciences, Mombasa, Kenya

Search for other papers by Tom Were in
Google Scholar
PubMed Close

Introduction Injection drug use and associated co-morbidities are an increasing public health burden in the world (1) . An estimated 15.9 million people worldwide are injection drug users (IDUs), comprising 3 and 10 million HIV and hepatitis C

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-15-0071
Volume/Issue:
Volume 4: Issue 4
Open access
Cecilia Follin Department of Endocrinology, Skåne University Hospital, Lund, Sweden

Search for other papers by Cecilia Follin in
Google Scholar
PubMed Close
and
Sven Karlsson Department of Endocrinology, Skåne University Hospital, Lund, Sweden

Search for other papers by Sven Karlsson in
Google Scholar
PubMed Close

( 9 ). In patients with acromegaly, impaired quality of life (QoL) – as assessed by specific questionnaires – has been reported even in patients who experience long-term cure ( 10 ). The chronic need for monthly injections of SSA might negatively

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0038
Volume/Issue:
Volume 5: Issue 4
Open access
Régis Coutant Department of Pediatric Endocrinology and Diabetology, Reference Center for Rare Pituiatry Diseases, University Hospital of Angers, Angers, France

Search for other papers by Régis Coutant in
Google Scholar
PubMed Close
,
Maithé Tauber Reference Center for the Prader-Willi syndrome and other rare obesities with feeding disorders (PRADORT), Children Hospital, CHU Toulouse, Toulouse, France
Pediatric team of the Clinical Investigation Center 9302/INSERM, Hospital of Children, Toulouse, France
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France

Search for other papers by Maithé Tauber in
Google Scholar
PubMed Close
,
Béatrice Demaret GRANDIR - French Growth Disorders Association, Asnières-sur-Seine, France

Search for other papers by Béatrice Demaret in
Google Scholar
PubMed Close
,
Robin Henocque Pfizer France, Paris France

Search for other papers by Robin Henocque in
Google Scholar
PubMed Close
,
Yves Brault Pfizer France, Paris France

Search for other papers by Yves Brault in
Google Scholar
PubMed Close
,
François Montestruc eXYSTAT, Malakoff, France

Search for other papers by François Montestruc in
Google Scholar
PubMed Close
,
Olivier Chassany Health Economics Clinical Trial Unit (URC-ECO), Hospital of Hotel-Dieu, AP-HP, Paris, France
Patient-Reported Outcomes Unit (PROQOL), UMR 1123, University Paris Cité, INSERM, Paris, France

Search for other papers by Olivier Chassany in
Google Scholar
PubMed Close
,
Michel Polak Hôpital Universitaire Necker Enfants Malades, Pediatric Endocrinology, Gynecology and Diabetology, Imagine Institute, INSERM U1163, Cochin Institute, INSERM U1016, Centre de référence des pathologies endocriniennes rares de la croissance et du développement, Université de Paris Cité, Paris, France

Search for other papers by Michel Polak in
Google Scholar
PubMed Close
, and
the QOLITHOR Study Group
Search for other papers by the QOLITHOR Study Group in
Google Scholar
PubMed Close
the QOLITHOR Study Group

improvement of psychosocial problems ( 3 , 4 ) and improvement in quality of life (QOL) ( 5 , 6 ). In addition, rhGH injections are well tolerated ( 7 , 8 ) even if adherence to treatment was shown as suboptimal ( 9 ). The majority of currently available

Article Type:
Research Article
Collections:
Paediatric Endocrinology
DOI:
https://doi.org/10.1530/EC-22-0464
Volume/Issue:
Volume 12: Issue 4
Open access
Ashley N Reeb Department of Otolaryngology, Head and Neck Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

Search for other papers by Ashley N Reeb in
Google Scholar
PubMed Close
,
Andrea Ziegler Department of Otolaryngology, Head and Neck Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

Search for other papers by Andrea Ziegler in
Google Scholar
PubMed Close
, and
Reigh-Yi Lin Department of Otolaryngology, Head and Neck Surgery, Saint Louis University School of Medicine, Saint Louis, Missouri, USA

Search for other papers by Reigh-Yi Lin in
Google Scholar
PubMed Close

microenvironment. Previously, we and other laboratories developed an orthotopic thyroid cancer model that faithfully recapitulates the clinical characteristics of advanced thyroid cancer ( 1 , 2 , 3 , 4 ). In addition, tail vein or intracardiac injection models

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-15-0114
Volume/Issue:
Volume 5: Issue 2
Open access
Esben S Lauritzen The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark

Search for other papers by Esben S Lauritzen in
Google Scholar
PubMed Close
,
Nikolaj Rittig The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark

Search for other papers by Nikolaj Rittig in
Google Scholar
PubMed Close
,
Ermina Bach The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark

Search for other papers by Ermina Bach in
Google Scholar
PubMed Close
,
Niels Møller The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus C, Denmark

Search for other papers by Niels Møller in
Google Scholar
PubMed Close
, and
Mette Bjerre The Medical Research Laboratories, Institute of Clinical Research, Aarhus University, Aarhus C, Denmark

Search for other papers by Mette Bjerre in
Google Scholar
PubMed Close

), healthy and without regular intake of medicine were investigated two times: (1) After isotonic saline injection (bolus saline) and (2) after an Escherichia coli endotoxin (10,000 USP Endotoxin, lot H0K354; The United States Pharmacopeial Convention, Inc

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0103
Volume/Issue:
Volume 6: Issue 1
Open access
Myrtille Fouché Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Myrtille Fouché in
Google Scholar
PubMed Close
,
Yves Bouffard Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Yves Bouffard in
Google Scholar
PubMed Close
,
Mary-Charlotte Le Goff Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Mary-Charlotte Le Goff in
Google Scholar
PubMed Close
,
Johanne Prothet Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Johanne Prothet in
Google Scholar
PubMed Close
,
François Malavieille Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by François Malavieille in
Google Scholar
PubMed Close
,
Pierre Sagnard Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Pierre Sagnard in
Google Scholar
PubMed Close
,
Françoise Christin Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Françoise Christin in
Google Scholar
PubMed Close
,
Davy Hayi-Slayman Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Davy Hayi-Slayman in
Google Scholar
PubMed Close
,
Arnaud Pasquer Department of Visceral Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Arnaud Pasquer in
Google Scholar
PubMed Close
,
Gilles Poncet Department of Visceral Surgery, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Gilles Poncet in
Google Scholar
PubMed Close
,
Thomas Walter Department of Hepatogastroenterology and Oncology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Search for other papers by Thomas Walter in
Google Scholar
PubMed Close
, and
Thomas Rimmelé Department of Anaesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
EA 7426 Hospices Civils de Lyon-University Claude Bernard Lyon 1-Biomérieux ‘Pathophysiology of Injury-Induced Immunosuppression’ Pi3, Lyon, France

Search for other papers by Thomas Rimmelé in
Google Scholar
PubMed Close

(HR) or blood pressure (BP)) ≥40%, not explained by surgical or anaesthetic management and regressive ≥20% within 5 min after the octreotide bolus injection; probable ioCS was defined as cases for which manifestations did not meet all criteria of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0324
Volume/Issue:
Volume 7: Issue 12
Open access
Fahim Ebrahimi Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Basel Hospital, Basel, Switzerland
Department of Clinical Research, University of Basel Hospital, Basel, Switzerland

Search for other papers by Fahim Ebrahimi in
Google Scholar
PubMed Close
,
Sandrine A Urwyler Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Basel Hospital, Basel, Switzerland
Department of Clinical Research, University of Basel Hospital, Basel, Switzerland

Search for other papers by Sandrine A Urwyler in
Google Scholar
PubMed Close
,
Philipp Schuetz Department of Clinical Research, University of Basel Hospital, Basel, Switzerland
Division of Endocrinology, Diabetes and Metabolism, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland

Search for other papers by Philipp Schuetz in
Google Scholar
PubMed Close
,
Beat Mueller Department of Clinical Research, University of Basel Hospital, Basel, Switzerland
Division of Endocrinology, Diabetes and Metabolism, University Department of Medicine, Kantonsspital Aarau, Aarau, Switzerland

Search for other papers by Beat Mueller in
Google Scholar
PubMed Close
,
Luca Bernasconi Department of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland

Search for other papers by Luca Bernasconi in
Google Scholar
PubMed Close
,
Peter Neyer Department of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland

Search for other papers by Peter Neyer in
Google Scholar
PubMed Close
,
Marc Y Donath Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Basel Hospital, Basel, Switzerland
Department of Clinical Research, University of Basel Hospital, Basel, Switzerland

Search for other papers by Marc Y Donath in
Google Scholar
PubMed Close
, and
Mirjam Christ-Crain Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, University of Basel Hospital, Basel, Switzerland
Department of Clinical Research, University of Basel Hospital, Basel, Switzerland

Search for other papers by Mirjam Christ-Crain in
Google Scholar
PubMed Close

anakinra, purchased by Swedish Orphan Biovitrum, or an identically appearing placebo twice-daily, as self-administered, subcutaneous injections for 4 weeks. Compliance to treatment was assessed by counting returned empty syringes, by keeping a medication

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0201
Volume/Issue:
Volume 8: Issue 6
Open access
Milou Cecilia Madsen Department of Internal Medicine and Center of Expertise on Gender Dysphoria, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

Search for other papers by Milou Cecilia Madsen in
Google Scholar
PubMed Close
,
Martin den Heijer Department of Internal Medicine and Center of Expertise on Gender Dysphoria, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands

Search for other papers by Martin den Heijer in
Google Scholar
PubMed Close
,
Claudia Pees Walaeus Library, Leiden University Medical Center, Leiden, the Netherlands

Search for other papers by Claudia Pees in
Google Scholar
PubMed Close
,
Nienke R Biermasz Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands

Search for other papers by Nienke R Biermasz in
Google Scholar
PubMed Close
, and
Leontine E H Bakker Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands

Search for other papers by Leontine E H Bakker in
Google Scholar
PubMed Close

-acting intramuscular injections, such as Sustanon®, are esters of testosterone (TE) that have been used for many years for the treatment of testosterone deficiency prior to the availability of transdermal testosterone preparations. However, they have to be administered

Article Type:
Review Article
Collections:
Reproduction
DOI:
https://doi.org/10.1530/EC-22-0112
Volume/Issue:
Volume 11: Issue 8
Open access